The Effect of GD-iExo-003 in Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2025-08-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blinded, placebo-controlled, dose-escalation trial.
The objective of this study is evaluating safety and preliminary efficacy of intravenous
exosomes derived from human induced pluripotent stem cell (GD-iExo-003) in acute ischemic
stroke.